Ketut Kwartantaya Winaya
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Udayana / Ngoerah General Hospital, Denpasar, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Energy-Based and Ablative Destructive Therapies Versus Surgical Excision for Primary Basal Cell Carcinoma: A Systematic Review and Meta-Analysis Nyoman Diah Asvini Sokawati Kesuma; Ketut Kwartantaya Winaya
Sriwijaya Journal of Radiology and Imaging Research Vol. 4 No. 2 (2026): Sriwijaya Journal of Radiology and Imaging Research
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjrir.v4i2.350

Abstract

Background: Surgical excision is the reference treatment for basal cell carcinoma (BCC), but energy-based and ablative therapies, including photodynamic therapy, radiotherapy and brachytherapy, laser ablation, electrochemotherapy and curettage-based destruction, are increasingly used. Objective: To quantify the loss of tumour control and the cosmetic gain of these therapies relative to excision. Methods: PubMed/MEDLINE, Scopus, Europe PMC and ClinicalTrials.gov were searched from inception for randomised and non-randomised controlled studies comparing these therapies with excision for primary BCC. The primary outcome was treatment failure. Risk ratios (RR) were pooled with Mantel–Haenszel random-effects models, and certainty was graded with GRADE. Results: Fourteen studies (11 randomised) were included; 12 studies with 1,737 lesions or patients informed the primary outcome. In randomised trials, failure was more frequent after ablative therapy (RR 5.34, 95% CI 2.76 to 10.33; I2=23.3%; moderate certainty). Across all studies the RR was 3.26 (95% CI 1.47 to 7.23; prediction interval 0.27 to 40.00), an absolute excess of 7.6 failures per 100 tumours; heterogeneity (I2=60.3%) was explained by study design. Early failure and late recurrence also increased. Good or excellent cosmesis was more frequent after photodynamic therapy in two trials (RR 1.87, 95% CI 1.54 to 2.26; low certainty), but not after radiotherapy or cryosurgery. Conclusion: Energy-based and ablative therapies increased the risk of treatment failure five-fold in randomised trials, while photodynamic therapy improved cosmesis. Excision should remain first-line when tumour control is the priority; non-surgical options suit selected thin, low-risk tumours or patients unfit for surgery, with imaging-supported selection and surveillance.